Induction of C Chemokine XCL1 (Lymphotactin/Single C Motif-1α /Activation-Induced, T Cell-Derived and Chemokine-Related Cytokine) Expression by HIV-1 Tat Protein

Journal of Immunology

Volumn 172, Issue 3, 2004, Pages 1888-1895

  Kim, Byung Oh ^a   Liu, Ying ^a   Zhou, Betty Y ^a   He, Johnny J ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA CHEMOKINE; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MICROGLIA; MONOCYTE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; T LYMPHOCYTE; UPREGULATION;

EID: 1642443931     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.3.1888     Document Type: Article

References (54)

1. Price, R. W., B. Brew, J. Sidtis, M. Rosenblum, A. C. Scheck, and P. Cleary. 1988. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586.
2. Gabuzda, D. H., and M. S. Hirsch. 1987. Neurologic manifestations of infection with human immunodeficiency virus: clinical features and pathogenesis. Ann. Intern. Med. 107:383.
3. Glass, J. D., S. L. Wesselingh, O. A. Selnes, and J. C. McArthur. 1993. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 43:2230.
4. Navia, B., E. S. Cho, C. K. Petito, and R. W. Price. 1986. The AIDS dementia complex. II. Neuropathology. Ann. Neurol. 19:525.
5. Epstein, L. G., and H. E. Gendelman. 1993. Human immunodeficiency virus type I infection of the nervous system: pathogenetic mechanisms. Ann. Neurol. 33:429.
6. Genis, P., M. Jett, E. W. Bernton, T. Boyle, H. A. Gelbard, K. Dzenko, R. W. Keane, L. Resnick, Y. Mizrachi, D. J. Volsky, et al. 1992. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176:1703.
7. Petito, C. K., and K. S. Cash. 1992. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann. Neurol. 32:658.
8. Power, C., P. A. Kong, T. O. Crawford, S. Wesselingh, J. D. Glass, J. C. McArthur, and B. D. Trapp. 1993. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann. Neurol. 34:339.
9. Wiley, C. A., and C. Achim. 1994. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann. Neurol. 36:673.
10. Langford, D., and E. Masliah. 2002. Role of trophic factors on neuroimmunity in neurodegenerative infectious diseases. J. Neurovirol. 8:625.
11. Ensoli, B., G. Barillari, S. Z. Salahuddin, R. C. Gallo, and F. Wong-Staal. 1990. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84.
12. Chang, H. C., F. Samaniego, B. C. Nair, L. Buonaguro, and B. Ensoli. 1997. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 11:1421.
13. Zauli, G., M. La Placa, M. Vignoli, M. C. Re, D. Gibellini, G. Furlini, D. Milani, M. Marchisio, M. Mazzoni, and S. Capitani. 1995. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. J. Acquired Immune Defic. Syndr. 10:306.
14. Kim, B. O., Y. Liu, Y. Ruan, Z. C. Xu, L. Schantz, and J. J. He. 2003. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am. J. Pathol. 162:1693.
15. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497.
16. Xiao, H., C. Neuveut, H. L. Tiffany, M. Benkirane, E. A. Rich, P. M. Murphy, and K. T. Jeang. 2000. Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc. Natl. Acad. Sci. USA 97:11466.
17. Frankel, A. D., and C. O. Pabo. 1988. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189.
18. Liu, Y., M. Jones, C. M. Hingtgen, G. Bu, N. Laribee, R. E. Tanzi, R. D. Moir, A. Nath, and J. J. He. 2000. Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat. Med. 6:1380.
19. Chauhan, A., J. Turchan, C. Pocernich, A. Bruce-Keller, S. Roth, D. A. Butterfield, E. O. Major, and A. Nath. 2003. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J. Biol. Chem. 278:13512.
20. Jones, M., K. Olafson, M. R. Del Bigio, J. Peeling, and A. Nath. 1998. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J. Neuropathol. Exp. Neurol. 57:563.
21. Rappaport, J., J. Joseph, S. Croul, G. Alexander, L. Del Valle, S. Amini, and K. Khalili. 1999. Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein. Tat. J. Leukocyte Biol. 65:458.
22. Hudson, L., J. Liu, A. Nath, M. Jones, R. Raghavan, O. Narayan, D. Male, and I. Everall. 2000. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J. Neurovirol. 6:145.
23. Bell, J. E., A. Busuttil, J. W. Ironside, S. Rebus, Y. K. Donaldson, P. Simmonds, and J. F. Peutherer. 1993. Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J. Infect. Dis. 168:818.
24. Falangola, M. F., A. Hanly, B. Galvao-Castro, and C. K. Petito. 1995. HIV infection of human choroid plexus: a possible mechanism of viral entry into the CNS. J. Neuropathol. Exp. Neurol. 54:497.
25. + T-cell infiltrates in human immunodeficiency virus type 1-associated central nervous system disease in children. Clin. Diagn. Lab. Immunol. 6:105.
26. + cells accumulate in the brains of acquired immunodeficiency syndrome patients with human immunodeficiency virus encephalitis. J. Neurovirol. 9:36.
27. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121.
28. Bonwetsch, R., S. Croul, M. W. Richardson, C. Lorenzana, L. D. Valle, A. E. Sverstiuk, S. Amini, S. Morgello, K. Khalili, and J. Rappaport. 1999. Role of HIV-1 Tat and CC chemokine MIP-1α in the pathogenesis of HIV associated central nervous system disorders. J. Neurovirol. 5:685.
29. Lane, T. E., V. C. Asensio, N. Yu, A. D. Paoletti, I. L. Campbell, and M. J. Buchmeier. 1998. Dynamic regulation of α- and β-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J. Immunol. 160:970.
30. Schmidtmayerova, H., H. S. Nottet, G. Nuovo, T. Raabe, C. R. Flanagan, L. Dubrovsky, H. E. Gendelman, A. Cerami, M. Bukrinsky, and B. Sherry. 1996. Human immunodeficiency virus type 1 infection alters chemokine β peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA 93:700.
31. Tong, N., S. W. Perry, Q. Zhang, H. J. James, H. Guo, A. Brooks, H. Bal, S. A. Kinnear, S. Fine, L. G. Epstein. et al. 2000. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J. Immunol. 164:1333.
32. Kutsch, O., J. Oh, A. Nath, and E. N. Benveniste. 2000. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J. Virol. 74:9214.
33. Conant, K., A. Garzino-Demo, A. Nath, J. C. McArthur, W. Halliday, C. Power, R. C. Gallo, and E. O. Major. 1998. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA 95:3117.
34. Albini, A., R. Benelli, D. Giunciuglio, T. Cai, G. Mariani, S. Ferrini, and D. M. Noonan. 1998. Identification of a novel domain of HIV tat involved in monocyte chemotaxis. J. Biol. Chem. 273:15895.
35. Benelli, R., R. Mortarini, A. Anichini, D. Giunciuglio, D. M. Noonan, S. Montalti, C. Tacchetti, and A. Albini. 1998. Monocyte-derived dendritic cells and monocytes migrate to HIV-Tat RGD and basic peptides. AIDS 12:261.
36. Lafrenie, R. M., L. M. Wahl, J. S. Epstein, I. K. Hewlett, K. M. Yamada, and S. Dhawan. 1996. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells: a mechanism of HIV pathogenesis. J. Immunol. 156:1638.
37. Lafrenie, R. M., L. M. Wahl, J. S. Epstein, I. K. Hewlett, K. M. Yamada, and S. Dhawan. 1996. HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. J. Immunol. 157:974.
38. Gibellini, D., G. Zauli, M. C. Re, D. Milani, G. Furlini, E. Caramelli, S. Capitani, and M. La Placa. 1994. Recombinani human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially up-regulates IL-6 and TGF-β1 mRNA expression and protein synthesis in peripheral blood monocytes. Br. J. Haematol. 88:261.
39. Zauli, G., B. R. Davis, M. C. Re, G. Visani, G. Furlini, and M. La Placa. 1992. Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 80:3036.
40. Chen, P., M. Mayne, C. Power, and A. Nath. 1997. The Tat protein of HIV-1 induces tumor necrosis factor-α production: implications for HIV-1-associated neurological diseases. J. Biol. Chem. 272:22385.
41. Ito, M., T. Ishida, L. He, F. Tanabe, Y. Rongge, Y. Miyakawa, and H. Terunuma. 1998. HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses 14:845.
42. Onishi, M., S. Kinoshita, Y. Morikawa, A. Shibuya, J. Phillips, L. L. Lanier. D. M. Gorman, G. P. Nolan, A. Miyajima, and T. Kitamura. 1996. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24:324.
43. Yoshida, T., I. Ishikawa, Y. Ono, T. Imai, R. Suzuki, and O. Yoshie. 1999. An activation-responsive element in single C motif-1/lympholactin promoter is a site of constitutive and inducible DNA-protein interactions involving nuclear factor of activated T cell. J. Immunol. 163:3295.
44. Hedrick, J. A., and A. Zlotnik. 1998. Lymphotactin. Clin. Immunol. Immunopathol. 87:218.
45. Kelner, G. S., J. Kennedy, K. B. Bacon, S. Kleyensteuber, D. A. Largaespada, N. A. Jenkins, N. G. Copeland, J. F. Bazan, K. W. Moore, T. J. Schall, et al. 1994. Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395.
46. Carroll, R., B. M. Peterlin, and D. Derse. 1992. Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators. J. Virol. 66:2000.
47. Barton, C. H., T. E. Biggs, T. R. Mee, and D. A. Mann. 1996. The human immunodeficiency virus type 1 regulatory protein Tat inhibits interferon-induced iNos activity in a murine macrophage cell line. J. Gen. Virol. 77:1643.
48. Caldwell, R. L., B. S. Egan, and V. L. Shepherd. 2000. HIV-1 Tat represses transcription from the mannose receptor promoter. J. Immunol. 165:7035.
49. Middel, P., P. Thelen, S. Blaschke, F. Polzien, K. Reich, V. Blaschke, A. Wrede, K. M. Hummel, B. Gunawan, and H. J. Radzun. 2001. Expression of the T-cell chemoattractant chemokine lymphotactin in Crohn's disease. Am. J. Pathol. 159:1751.
50. Wisniewski, H. M., and A. S. Lossinsky. 1991. Structural and functional aspects of the interaction of inflammatory cells with the blood-brain barrier in experimental brain inflammation. Brain Pathol. 1:89.
51. Bien, C. G., J. Bauer, T. L. Deckwerth, H. Wiendl, M. Deckert, O. D. Wiestler, J. Schramm, C. E. Elger, and H. Lassmann. 2002. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann. Neurol. 51:311.
52. Li, X., J. Josef, and W. A. Marasco. 2001. Hiv-1 Tat can substantially enhance the capacity of NIK to induce IκB degradation. Biochem. Biophys. Res. Commun. 286:587.
53. Gomez-Gonzalo, M., M. Carretero, J. Rullas, E. Lara-Pezzi, J. Aramburu, B. Berkhout, J. Alcami, and M. Lopez-Cabrera. 2001. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-κB/NF-AT and SPI-binding sites in the HIV-1 long terminal repeat promoter. J. Biol. Chem. 276:35435.
54. Kinoshita, S., L. Su, M. Amano, L. A. Timmerman, H. Kaneshima, and G. P. Nolan. 1997. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 6:235.